Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2025-11-19 00:00:00 ET · period of report 2025-11-17 · accession 0002020969-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-19 | 2025-11-17 | RXRX | Khan Najat | Chief R, D Commercial Off, Dir | F - Tax | $4.14 | -17.6K | 735.5K | -2% | -$72.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-11-17 | F | D | 17,584 | $4.14 | 735,538 | D | — | — |